2-pyrazolines are reported as antibacterial[@CIT1], antifungal[@CIT2][@CIT3][@CIT4], antimicrobial[@CIT5], antiviral[@CIT6], anti-arthritis[@CIT7] and antiinflammatory[@CIT7][@CIT8] agents. Encouraged by these facts, we selected to work on 1,3,5-trisubstituted-2-pyrazolines with different substitutions on the phenyl ring. The antibacterial activity and antifungal activity was screened by cup-plate agar diffusion method and the zone of inhibition for each microorganism at different concentrations of the compounds was measured.

Melting points of the compounds were determined on a Toshniwal Scientific melting point apparatus and are uncorrected. Purity of the compounds was checked by Thin Layer Chromatography using precoated Merck Silica gel GF~254~ micro TLC plates and spots were detected under UV. UV spectra were recorded on UV/Vis spectrophotometer (Shimadzu), UV-1601 PC, IR spectra were recorded in KBr disc on a FTIR_8300, KBr Press (Shimadzu) spectrophotometer at Manipal College Of Pharmaceutical Sciences, Manipal. ^1^H NMR spectra (DMSO-d~6~) were obtained using Varian 300 MHz Mercury NMR spectrometer from Shimadzu Analytical Technique Center, Department of Chemistry, Pune University, Pune. Mass spectra of the synthesized compounds were obtained using Mass Spectrometer, Shimadzu QP5050 from Shimadzu Analytical Technique Center, Department of Chemistry, Pune University, Pune. Chemicals were obtained from S.D. Fine Chemicals Ltd dealers from Mangalore.

Synthesis of 1,3,5-trisubstituted-2-pyrazolines \[compound P13 (5-(4-fluorophenyl)-3-(4-fluorophenyl)-1-isonicotinoyl-pyrazoline)\][@CIT9][@CIT10] was performed by taking equimolar quantities (0.02 mol) of 4-fluoro benzaldehyde and 4-fluoro acetophenone in a 250 ml conical flask and dissolving in minimum amount of 95% ethanol. The mixture was then cooled and 8 ml of 10% potassium hydroxide solution was added. The mixture was stirred over a magnetic stirrer for a period of 24 h and left in an ice chest overnight. On the next day, the mixture was poured into a beaker containing ice-cold water. Then the aqueous layer was acidified with conc. HCl. The precipitated chalcone (1-(4-fluorophenyl)-3-(4-fluorophenyl)-2-propen-1-one) was filtered at pump and recrystallized from aqueous methanol. IR (KBr)cm^−1^:1598.9 (C = C), 1660.6 (C = O), 3072.4 (C-H). (1-(4-fluorophenyl)-3-(4-fluorophenyl)-2-propen-1-one) (0.05 mol) was added to isoniazid (0.1 mol) in a 100 ml R.B.F. containing 30 ml of N, N-dimethylformamide. The mixture was refluxed at 120° to 140° for a period of 8-10 h. After cooling, the reaction mixture was poured into a beaker containing ice-cold water and the product separated was scooped off and dried over a clean filter paper. The pyrazoline obtained was recrystallized using benzene-petroleum ether. Single spot on TLC established the purity of the compound. Solvent system used was Hexane: ethyl acetate in 4:1 ratio. IR (KBr)cm^−1^: 1641.3 (N-C = O), 1595.0 (C = N), 1215.1 (C-N), 2914.2 (C-H,CH~2~),^1^H NMR (δ values) ppm: aromatic hydrogens 6.7-8.6 δ (m, 12H,Ar-H), CH~2~ methylene 3.4 δ (s, 2H, CH~2~), CH methine 5.6 δ (d, 1H,CH-Ar). The other derivatives were prepared in a similar way with different substituted chalcones according to the scheme of synthesis given in [fig. 1](#F0001){ref-type="fig"}. The physical data of the synthesized compounds is given in [Table 1](#T0001){ref-type="table"}.

![Scheme for pyrazoline synthesis.\
Where, R~1~ = -H, -Cl(m), -Cl(p), -F(p), -OCH~3~(p), -OCH~3~(m, p), - N(CH~3~)~2~(p), -NO~2~(m) R~2~ = -F(p), -Cl(p), -Br(p), -OCH~3~(p).](IJPhS-70-105-g001){#F0001}

###### 

PHYSICAL DATA OF THE SYNTHESIZED PYRAZOLINES

  Pyrazoline   R~1~               R~2~          R~f~ Value   m.p. (°)   \% Yield
  ------------ ------------------ ------------- ------------ ---------- ----------
  P01          -F (p)             -Cl (p)       0.73         132-133    51
  P02          -Cl (m)            -Cl (p)       0.64         123-125    55
  P03          -OCH~3~ (p)        -Cl (p)       0.77         172-174    58
  P04          -N(CH~3~)~2~ (p)   -Cl (p)       0.11         163-165    49
  P05          -Cl (p)            -Cl (p)       0.17         86-88      34
  P06          -OCH~3~ (m,p)      -Cl (p)       0.11         166-167    50
  P07          -N(CH~3~)~2~ (p)   -OCH~3~ (p)   0.17         188-190    52
  P08          -Cl (p)            -OCH~3~ (p)   0.16         214-215    59
  P09          -NO~2~ (m)         -OCH~3~ (p)   0.31         170-172    36
  P10          -OCH~3~ (m,p)      -OCH3 (p)     0.30         188-189    47
  P11          -F (p)             -Br (p)       0.15         111-113    53
  P12          -N(CH~3~)~2~ (p)   -Br (p)       0.14         96-98      32
  P13          -F (p)             -F (p)        0.19         112-114    44
  P14          -Cl (p)            -F (p)        0.15         162-163    65
  P15          -OCH~3~ (p)        -F (p)        0.12         157-158    58

All the compounds gave satisfactory spectral and elemental data

All the synthesized compounds were screened *in vitro* for antibacterial activity against *Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa*, *Escherichia coli* at the concentrations 200, 300, 400 and 500 mg/ml and for antifungal activity against *Aspergillus niger* at 100, 200, 300, 400 μg/ml by cup-plate agar diffusion method[@CIT11]. The concentrations used in screening were chosen after determining the MICs of each compound. The solvent used was dimethylsulfoxide (DMSO) further diluted with water. Muller Hinton agar was used as the growth medium for the bacterial species and Sabouraud\'s agar was the growth medium for the fungal species. DMSO was used as a control for all the type of microorganisms. The control showed no activity against the strains of microorganisms used. Antimicrobial activity and antifungal activity was measured as a function of diameter of zone of inhibition (mm). The results were compared with standard drugs ciprofloxacin for antibacterial activity and fluconazole for antifungal activity by measuring the zone of inhibition in mm at 200 and 100 μg/ml respectively. At 200 μg/ml, compounds P14 and P15 were found most effective of the synthesized compounds against *S. aureus*, (zone of inhibition 15 mm) and compound P14 is the most effective among the synthesized compounds at 200 μg/ml against *B. subtilis*, (zone of inhibition 16 mm). Compounds P02, P08, P09, P10, P11 were the most effective among the synthesized compounds against *E. coli*, (zone of inhibition 15 mm) and compound P05 was the most effective at 200 μg/ml among the synthesized compounds against *P. aeruginosa*, (zone of inhibition 21 mm). At 100 μg/ml the maximum diameter of zone of inhibition (20 mm) against *Aspergillus niger* was observed for compound P08; indicating that, it is the most effective among the synthesized compounds against *Aspergillus niger*. The results of the antibacterial and antifungal activity are given in [Table 2](#T0002){ref-type="table"}.

###### 

RESULTS OF *IN VITRO* ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY

  Code   *S. aureus*   *B. subtilis*   *E. coli*   *P. aeruginosa*   *A. niger*                                                                         
  ------ ------------- --------------- ----------- ----------------- ------------ ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  P01    12            13              15          16                13           14   16   17   12   13   14   16   \-   \-   \-   \-   12   13   14   16
  P02    14            16              18          22                13           14   15   17   15   17   19   21   15   16   18   20   \-   \-   \-   \-
  P03    13            14              15          17                14           16   17   19   12   14   16   17   \-   \-   \-   \-   12   13   15   16
  P04    13            14              15          17                12           13   15   16   12   13   14   16   18   20   22   26   14   15   16   18
  P05    12            14              16          17                \-           \-   16   19   13   14   16   17   21   24   26   28   \-   \-   \-   \-
  P06    12            13              14          16                12           13   14   15   12   13   14   15   20   22   23   25   \-   \-   \-   \-
  P07    \-            \-              \-          13                12           13   14   16   12   13   14   16   15   19   22   25   19   21   23   24
  P08    12            13              15          16                12           14   15   17   15   18   21   23   \-   \-   \-   \-   20   22   24   26
  P09    12            14              16          18                \-           \-   \-   \-   15   16   17   19   12   16   20   23   16   18   20   22
  P10    13            15              17          20                \-           12   14   16   15   17   19   21   18   21   24   26   15   17   19   20
  P11    12            13              14          16                12           13   15   16   15   17   21   23   17   19   22   24   15   16   18   19
  P12    12            14              15          17                \-           \-   12   14   12   14   15   17   17   20   23   25   16   18   20   22
  P13    12            13              14          15                12           14   16   19   12   13   16   18   13   15   17   20   \-   \-   \-   \-
  P14    15            17              19          21                16           18   20   22   14   16   18   20   16   18   20   23   \-   \-   \-   \-
  P15    15            17              18          20                14           15   16   18   12   13   14   16   \-   \-   \-   \-   \-   \-   \-   \-

A, B, C, D, E indicates concentration of compounds at 100 μg/ml, 200 μg/ml, 300 μg/ml, 400 μg/ml and 500 μg/ml, respectively. Ciprofloxacin (200 μg/ml) had 26 mm zone of inhibition for *S. aureus*, 25 mm for *B. subtilis*, 26 mm for *E. coli*, 30 mm for *P. aeruginosa* microorganisms respectively and fluconazole (100 μg/ml) had 28 mm zone of inhibition for *A. niger organism*. Figures indicate diameter of the zone of inhibition in mm including the diameter of cup (i.e. 10 mm). '-' indicates resistance.
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